Skip to main content
. 2022 Feb 13;10(2):434. doi: 10.3390/biomedicines10020434

Figure 2.

Figure 2

(a) Annual FVC changes in all SSc-ILD patients and in the specific treatment groups. Description of what is contained in the first panel; (b) annual DLCO changes in each specific treatment group; DLCO, diffusing capacity for carbon monoxide; FVC, forced vital capacity; I = ISU therapy; NT = No treatment; I = ISU therapy, B = Biological therapy.